Teachers Retirement System of The State of Kentucky Reduces Stake in Hologic, Inc. (NASDAQ:HOLX)


Share on StockTwits

Teachers Retirement System of The State of Kentucky cut its position in Hologic, Inc. (NASDAQ:HOLX) by 8.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 125,397 shares of the medical equipment provider’s stock after selling 12,094 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Hologic were worth $9,133,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HOLX. FMR LLC lifted its holdings in shares of Hologic by 31.0% in the 4th quarter. FMR LLC now owns 26,439,111 shares of the medical equipment provider’s stock valued at $1,925,560,000 after buying an additional 6,263,184 shares during the period. Norges Bank acquired a new stake in shares of Hologic in the 4th quarter valued at approximately $194,467,000. BlackRock Inc. lifted its holdings in shares of Hologic by 4.0% in the 4th quarter. BlackRock Inc. now owns 20,838,302 shares of the medical equipment provider’s stock valued at $1,517,655,000 after buying an additional 808,123 shares during the period. UBS Asset Management Americas Inc. lifted its holdings in shares of Hologic by 34.4% in the 4th quarter. UBS Asset Management Americas Inc. now owns 2,323,223 shares of the medical equipment provider’s stock valued at $169,200,000 after buying an additional 594,505 shares during the period. Finally, Nordea Investment Management AB lifted its holdings in shares of Hologic by 113.5% in the 4th quarter. Nordea Investment Management AB now owns 1,041,590 shares of the medical equipment provider’s stock valued at $75,859,000 after buying an additional 553,642 shares during the period. 92.43% of the stock is owned by hedge funds and other institutional investors.

Shares of NASDAQ HOLX opened at $72.90 on Thursday. Hologic, Inc. has a 1 year low of $37.26 and a 1 year high of $85.00. The firm has a market cap of $18.78 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 0.62 and a beta of 1.27. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.47 and a current ratio of 1.79. The stock’s 50-day simple moving average is $73.49 and its 200-day simple moving average is $72.88.

Hologic (NASDAQ:HOLX) last announced its earnings results on Wednesday, January 27th. The medical equipment provider reported $2.86 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.14 by $0.72. Hologic had a return on equity of 45.24% and a net margin of 29.53%. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same period in the previous year, the company earned $0.61 earnings per share. The company’s revenue for the quarter was up 89.3% compared to the same quarter last year. As a group, research analysts predict that Hologic, Inc. will post 7.17 EPS for the current year.

HOLX has been the subject of several recent analyst reports. Jefferies Financial Group raised their price target on Hologic from $106.00 to $110.00 and gave the company a “buy” rating in a report on Monday. Robert W. Baird raised their price objective on Hologic from $84.00 to $91.00 and gave the company a “buy” rating in a research note on Monday, March 1st. BTIG Research raised their price objective on Hologic from $84.00 to $91.00 and gave the company a “buy” rating in a research note on Monday, February 22nd. Wells Fargo & Company raised their price target on Hologic from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, January 28th. Finally, Morgan Stanley raised their price objective on Hologic from $80.00 to $84.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 15th. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Hologic presently has an average rating of “Buy” and an average price target of $85.19.

In related news, insider Benjamin Jordan Cohn sold 8,396 shares of the business’s stock in a transaction dated Thursday, February 4th. The stock was sold at an average price of $84.31, for a total value of $707,866.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.00% of the stock is owned by insiders.

Hologic Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

Recommended Story: How to find the components of the quick ratio

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.